Indonesia’s policy misstep is Vietnam’s opportunity to seize the sweet spot as Southeast Asia’s pharmaceutical hub

• Indonesia is actively driving out biopharmaceutical and other sophisticated ventures, requiring the compulsory licensing of any non-indigenous pharmaceutical products
• This intellectual property grab will result in the list of drugs not available in Indonesia to grow even longer